Unknown

Dataset Information

0

The Brazilian TP53 mutation (R337H) and sarcomas.

ABSTRACT: Sarcomas represent less than 1% of all solid neoplasms in adults and over 20% in children. Their etiology is unclear, but genetic susceptibility plays an important role in this scenario. Sarcoma is central in Li-Fraumeni Syndrome (LFS), a familial predisposition cancer syndrome. In Brazil, the high prevalence of p.Arg337His mutations in the TP53 gene brings about a unique condition: a cluster of LFS. In the present work, we studied 502 sarcoma patients not selected by age or family history in an attempt to assess the impact of the so-called "Brazilian germline TP53 mutation" (p.Arg337His) on this tumor type. We found that 8% of patients are carriers, with leiomyosarcoma being the main histologic type of sarcoma, corresponding to 52.5% of the patients with the mutated TP53 gene. These findings emphasize the importance of genetic counseling and can better guide the management of sarcoma patients.

SUBMITTER: Volc SM 

PROVIDER: S-EPMC6980636 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Sarcomas represent less than 1% of all solid neoplasms in adults and over 20% in children. Their etiology is unclear, but genetic susceptibility plays an important role in this scenario. Sarcoma is central in Li-Fraumeni Syndrome (LFS), a familial predisposition cancer syndrome. In Brazil, the high prevalence of p.Arg337His mutations in the TP53 gene brings about a unique condition: a cluster of LFS. In the present work, we studied 502 sarcoma patients not selected by age or family history in an  ...[more]

Similar Datasets

Unknown Ancestry of the Brazilian TP53 c.1010G>A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p.
| S-EPMC4664269 | biostudies-literature
Unknown Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.
| S-EPMC2631588 | biostudies-literature
Unknown Mouse Homolog of the Human <i>TP53</i> R337H Mutation Reveals Its Role in Tumorigenesis.
| S-EPMC6139041 | biostudies-literature
Unknown Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.
| S-EPMC3808236 | biostudies-literature
Unknown Inhibin alpha-subunit (INHA) gene and locus changes in paediatric adrenocortical tumours from TP53 R337H mutation heterozygote carriers.
| S-EPMC1735776 | biostudies-other
Unknown The Common Germline <i>TP53-R337H</i> Mutation Is Hypomorphic and Confers Incomplete Penetrance and Late Tumor Onset in a Mouse Model.
| S-EPMC8137600 | biostudies-literature
Unknown TP53 in bone and soft tissue sarcomas.
| S-EPMC6746598 | biostudies-literature
Unknown Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
| S-EPMC5738920 | biostudies-literature
Unknown Frequency of the TP53 R337H variant in sporadic breast cancer and its impact on genomic instability.
| S-EPMC7539008 | biostudies-literature
Transcriptomics The common germline TP53-R337H mutation is hypomorphic and confers incomplete tumor penetrance and late tumor onset in a mouse model
2021-03-01 | GSE166819 | GEO